MedDataX Logo

Navigator ACT Group Intervention for Parents of Children with Disabilities

NCT03830476 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2024-09-23

No results posted yet for this study

Summary

The main purpose of the pragmatic multicenter studies is to investigate the trransdiagnostic, manualized Acceptance and Commitment Therapy (ACT) based group treatment (Navigator ACT) for treatment of stress and distress in parents of children with disabilities, and to investigate the concept of parental psychological flexibility. The first phase includes a feasibility study (n=94) of the Navigator ACT for parents of children (0-17 years) with disabilties who participate in the Navigator ACT group treatment after being screened for symptoms of stress, depression and anxiety associated with the challenges of parenting. In the second phase (if treatment proves feasible), a randomised controlled trial (RCT) is conducted. In the RCT, approximately n=100 parents of children with disabilties were expected to be included, divided into experiment- and control groups. The recruitment takes places in several regions in Sweden. In addition, a psychometric evaluation of the main outcome instrument used in these studies, is going to be conducted. The Parental Acceptance and Action Questionnaire (PAAQ). In an additional study (expected n= ca 600), will focus on factors that explain treatment outcome and attrition.

Conditions

  • Parenting
  • Stress
  • Disability, Developmental
  • Behavior, Child
  • Acceptance and Action Processes
  • Parent-Child Relations
  • Experiential Avoidance
  • Depression, Anxiety

Interventions

BEHAVIORAL

Acceptance- and Commitment therapy group for parents to children with disabilities

ACT groups adjusted for parents of children with (any kind of) disabilities.

BEHAVIORAL

Treatment as usual.

Treatment as usual within outpatient disability services.

Sponsors & Collaborators

  • Region Stockholm

    collaborator OTHER_GOV

  • Karolinska Institutet

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-02
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Sweden

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03830476 on ClinicalTrials.gov